§ Lord Morris of Manchesterasked Her Majesty's Government:
Further to the Written Answer by the Lord Warner on 6 October (WA 42), whether they will take steps to establish at the earliest possible date the number of haemophilia patients who have been informed by the National Health Service that blood products from donors diagnosed with vCJD were used in their treatment. [HL4697]
§ The Parliamentary Under-Secretary of State, Department of Health (Lord Warner)We do not have any plans to collect this information. Any such collection would raise difficult issues over patient confidentiality.
§ Lord Morris of Manchesterasked Her Majesty's Government:
What was the membership of the vaccines subgroup of the Committee on Safety of Medicines at its meeting on 10 February following the request to the committee to review the licensing information on the administration of the anthrax vaccine. [HL5113]
§ Lord WarnerThe membership of the vaccines subgroup of the Committee on Safety of Medicines (CSM) is detailed as follows:
MEMBERSHIP OF THE AD HOC WORKING GROUP OF THE BIOLOGICALS SUB-COMMITTEE AND THE VACCINES WORKING GROUP 10 February 2003
81WA
- Professor Gordon W Duff
- Professor Deborah Ashby
- Professor Derek H Calam
- Dr Michael Corbel
- Dr Stephen C Inglis
- Professor Donald J Jeffries
- Dr Elizabeth Miller
- Professor Michael J S Langman
- OBSERVER
- Professor A M Breckenridge
The vaccines subgroup of the CSM also met on 4 March to consider the anthrax vaccine:
MEMBERSHIP OF THE AD HOC WORKING GROUP OF THE BIOLOGICALS SUB-COMMITTEE AND THE VACCINES WORKING GROUP 4 March 2003
- Professor Gordon W Duff
- Dr Barbara A Bannister
- Professor Peter Blain
- Dr Chris Box
- Professor Derek H Calam
- Dr Michael Corbel
- Dr Stephen C Inglis
- Professor Donald J Jeffries
- Dr Elizabeth Miller
- Emeritus Professor Geoffrey C Schild
- Dr David Salisbury
- OBSERVER
- Professor A M Breckenridge